Gene-Edited CAR-T Delivers New Hope in Deadly T-Cell Leukemia: Research Shows
London: A novel gene-edited immunotherapy has demonstrated encouraging outcomes for children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL), a rare and highly aggressive blood cancer with…